Dry mRNA vaccine patches reveal design rules for room-temperature storage
· Medical Xpressedited by Stephanie Baum, reviewed by Andrew Zinin
Stephanie Baum
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
New research could help make future mRNA vaccines easier to store and distribute. The study, involving RMIT University, the Massachusetts Institute of Technology and Harvard Medical School, identified conditions that help protect the particles that carry mRNA in dry vaccine patches, offering practical guidance for future patch design.
Published in Advanced Functional Materials, the study examines what happens to the fragile particles used to carry mRNA when they are dried into the dissolvable material used in microneedle patches. The patches use hundreds of tiny tips to deliver the vaccine into the skin as an alternative to traditional injections.
Reducing the need for cold-chain logistics could help remove one barrier to vaccine delivery, particularly in lower-resource settings. In 2024, 14.3 million children globally received no vaccines at all, according to the World Health Organization and UNICEF.
The paper builds on earlier research led by MIT showing the patches could be printed and stored at room temperature using a model mRNA system.
This new study goes further by explaining why some dry patch formulations perform better than others, drawing on RMIT's materials characterization expertise, MIT's work in microneedle and mRNA delivery technologies, and Harvard Medical School expertise in virology and immunology.
How drying affects the particles
Lead author Dr. Brendan Dyett from RMIT said the findings represent an important step toward making vaccines easier and cheaper to distribute.
"Many mRNA vaccines need to be stored at very low temperatures, adding cost and complexity to transport and delivery," Dyett said. "Our study helps explain how the particles that carry mRNA respond to drying and rehydration, which is an important step toward designing future vaccine patches that are more stable and practical to distribute."
The team used advanced imaging and X-ray techniques to study particles that carry mRNA before drying, during drying and after rehydration. This allowed the researchers to see how the particles changed through the process and determine which formulation conditions best preserved their structure and biological activity.
The study found that both the design of the nanoparticles and the amount of polymer used in the patch material influenced how well the particles survived drying and redissolving, providing practical guidance for future dry mRNA vaccines and therapies.
From lab findings to broader use
Lead researcher RMIT Distinguished Professor Calum Drummond AO said the work could help pave the way for mRNA vaccines and treatments that are more practical to use in a wider range of settings.
"This research is helping build the foundation for microneedle patches that could make advanced vaccines and therapies simpler to use and easier to access," Drummond said. "The long-term goal is to support technologies that are not only effective but practical for the places and communities that need them most."
Next steps include further optimizing the nanoparticle and patch formulations, testing how the design translates to immune responses, and exploring whether similar approaches could be applied to other mRNA medicines.
Publication details
Brendan P. Dyett et al, Exploring an Alternative to mRNA Vaccine Cold Chain Storage: MRNA‐Lipid Nanoparticle Stability When Dried in a Polymer Matrix, Advanced Functional Materials (2026). DOI: 10.1002/adfm.75716
Journal information: Advanced Functional Materials
Key medical concepts
RNA, MessengerMicroneedle Drug Delivery SystemNanoparticles
Clinical categories
Clinical pharmacologyPreventive medicineCommon illnesses & Prevention Provided by RMIT University Who's behind this story?
Stephanie Baum
Master's in TESOL from The New School. Passionate about language learning and editing science news on biology and space exploration. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Dry mRNA vaccine patches reveal design rules for room-temperature storage (2026, July 8) retrieved 8 July 2026 from https://medicalxpress.com/news/2026-07-dry-mrna-vaccine-patches-reveal.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.